WebDisclosure WebDisclosure
Basculer en Français
10885 Companies
236936 Keywords
165830 Articles
127152 Press releases
Headlines Articles Press releases Eyeson GmbH Remove
  1. Home
  2. Companies
  3. Eyeson GmbH
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 02/01/2024 at 08:00, 2 years 6 months ago

    Eyeson Announces 'Eyeson for Salesforce' on Salesforce AppExchange

    Eyeson launches Eyeson for Salesforce on Salesforce AppExchange, allowing seamless video communication within Salesforce for customer interactions. Benefits include guided workflows, secure documentation sharing, compliant recording, identity verification, and usage analytics
    Customer Engagement Video Communication Eyeson For Salesforce Salesforce AppExchange Enterprise Marketplace
    Logo of Eyeson GmbH
  • PRESS RELEASE

    published on 12/05/2023 at 06:00, 2 years 8 months ago

    Eyeson and Scotty Group Join Forces, Launching Innovative 'SCOTTY Telemed' Solution

    Eyeson and Scotty Group launch 'SCOTTY TeleMed' solution, connecting remote teams with experts via advanced video and satellite tech for public safety operations
    Eyeson Scotty Group SCOTTY TeleMed Video Communication Satellite Technology
    Logo of Eyeson GmbH
Accesswire
  • Published on 08/26/2026 at 23:00, 35 minutes ago

    Datametrex Announces Transition to Semi-Annual Financial Reporting

  • Published on 08/26/2026 at 22:30, 1 hour 5 minutes ago

    AI/ML Innovations Inc. Closes First Tranche of Private Placement

  • Published on 08/26/2026 at 22:30, 1 hour 5 minutes ago

    Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement

  • Published on 08/26/2026 at 21:15, 2 hours 20 minutes ago

    Announces Private Placement of Convertible Promissory Notes

  • Published on 08/26/2026 at 20:35, 3 hours ago

    RUM Reports Quarterly Financial Results for June 30, 2026

View all ACCESSWIRE
EQS Group
  • Published on 08/26/2026 at 23:05, 30 minutes ago

    Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta

  • Published on 08/26/2026 at 18:44, 4 hours 50 minutes ago

    AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results

  • Published on 08/26/2026 at 18:40, 4 hours 55 minutes ago

    MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM

  • Published on 08/26/2026 at 18:30, 5 hours 5 minutes ago

    Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China

  • Published on 08/26/2026 at 18:00, 5 hours 35 minutes ago

    MHM Corporate: reduces the nominal value of its shares to €0.011

View all EQS
Les Echos
  • Published on 08/26/2026 at 18:02, 5 hours 33 minutes ago

    Altareit: Altarea press release regarding the Primonial matter

  • Published on 08/26/2026 at 18:02, 5 hours 33 minutes ago

    Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial

  • Published on 08/26/2026 at 18:00, 5 hours 35 minutes ago

    Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)

  • Published on 08/26/2026 at 18:00, 5 hours 35 minutes ago

    Altarea : Conclusion d’un accord global mettant fin au litige entre Altarea et les actionnaires du groupe Praemia (ex-groupe Primonial)

  • Published on 08/26/2026 at 18:00, 5 hours 35 minutes ago

    KLARSEN : lance Dimea, sa nouvelle activité e-commerce dédiée aux compléments alimentaires

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy